Biosynthesis of the enediyne antitumor antibiotic C-1027 involves a new branching point in chorismate metabolism

Steven G. Van Lanen, Shuangjun Lin, Ben Shen

Research output: Contribution to journalArticlepeer-review

47 Scopus citations


C-1027 is an enediyne antitumor antibiotic composed of four distinct moieties: an enediyne core, a deoxy aminosugar, a β-amino acid, and a benzoxazolinate moiety. We now show that the benzoxazolinate moiety is derived from chorismate by the sequential action of two enzymes - SgcD, a 2-amino-2-deoxyisochorismate (ADIC) synthase and SgcG, an iron-sulfur, FMN-dependent ADIC dehydrogenase - to generate 3-enolpyruvoylanthranilate (OPA), a new intermediate in chorismate metabolism. The functional elucidation and catalytic properties of each enzyme are described, including spectroscopic characterization of the products and the development of a fluorescence-based assay for kinetic analysis. SgcD joins isochorismate (IC) synthase and 4-amino-4-deoxychorismate (ADC) synthase as anthranilate synthase component I (ASI) homologues that are devoid of pyruvate lyase activity inherent in ASI; yet, in contrast to IC and ADC synthase, SgcD has retained the ability to aminate chorismate identically to that observed for ASI. The net conversion of chorismate to OPA by the tandem action of SgcD and SgcG unambiguously establishes a new branching point in chorismate metabolism.

Original languageEnglish
Pages (from-to)494-499
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number2
StatePublished - Jan 15 2008


  • 2-amino-2-deoxyisochorismate dehydrogenase
  • 2-amino-2-deoxyisochorismate synthase
  • 3-enolpyruvoylanthranilate

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Biosynthesis of the enediyne antitumor antibiotic C-1027 involves a new branching point in chorismate metabolism'. Together they form a unique fingerprint.

Cite this